Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2024 | Story Lunga Luthuli | Photo SUPPLIED
Dr Kamwendo
Dr Juliet Kamwendo champions gender-inclusive climate action in Africa. Her expertise at the recently held AFR100 workshop highlighted vital steps towards sustainable and equitable development.

Dr Juliet Kamwendo, Lecturer and Programme Director for Gender Studies in the Centre for Gender and Africa Studies at the University of the Free State, is spearheading efforts to integrate gender considerations into Africa's climate restoration agenda. Reflecting on her involvement, Dr Kamwendo stated, "This is particularly crucial, as women make up almost 50% of the population in Africa, and the depletion and degradation of land affect them disproportionately."

She recently served as a gender expert at the AUDA-NEPAD AFR100 workshop in Ouagadougou, Burkina Faso, from 25 to 29 March 2024. This initiative aims to restore forests and degraded land across Africa by 2030, with a focus on gender equality.

The workshop emphasised the integration of gender perspectives into the AFR100 project, acknowledging the disproportionate impact of land degradation on women. Dr Kamwendo's expertise highlighted the need to empower women in climate change interventions, addressing existing gender inequalities exacerbated by environmental degradation.

“Women – who are primarily responsible for household food security and water provision – bear the brunt of environmental degradation, leading to increased workloads, reduced income opportunities, and heightened vulnerability to climate-related disasters. Furthermore, the loss of forest cover and biodiversity further exacerbates the challenges faced by women, particularly in rural areas where they depend heavily on natural resources for their livelihoods,” added Dr Kamwendo.

Her participation highlights academia's crucial role in fostering inclusive and sustainable development, emphasising interdisciplinary collaboration to tackle complex environmental challenges. Through initiatives such as AFR100, stakeholders are working towards a more resilient and gender-responsive future for Africa.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept